921034

Mylan Pharmaceuticals Inc — FEI 1110315

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 13, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Morgantown, WV (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)